Tumor location and type affect local recurrence and joint damage in tenosynovial giant cell tumor: a multi-center study

被引:11
|
作者
Ota, Takehiro [1 ,5 ]
Nishida, Yoshihiro [1 ,2 ]
Ikuta, Kunihiro [1 ]
Tsukushi, Satoshi [3 ]
Yamada, Kenji [4 ]
Kozawa, Eiji [5 ]
Urakawa, Hiroshi [1 ]
Imagama, Shiro [1 ]
机构
[1] Nagoya Univ, Dept Orthopaed Surg, Grad Sch Med, Nagoya, Aichi, Japan
[2] Nagoya Univ Hosp, Dept Rehabil Med, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan
[3] Aichi Canc Ctr Hosp, Dept Orthopaed Surg, Nagoya, Aichi, Japan
[4] Okazaki City Hosp, Dept Orthopaed Surg, Okazaki, Aichi, Japan
[5] Nagoya Mem Hosp, Dept Orthopaed Surg, Nagoya, Aichi, Japan
关键词
PIGMENTED VILLONODULAR SYNOVITIS; ARTHROSCOPIC TREATMENT; TENDON SHEATH; FOLLOW-UP; KNEE; SYNOVECTOMY; OUTCOMES; FOOT; EXPRESSION; ANKLE;
D O I
10.1038/s41598-021-96795-6
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Osteochondral destruction and a high recurrence rate after surgery are major concerns that make difficult the treatment course of tenosynovial giant cell tumor. The aims of this study were to elucidate rates of postoperative local recurrence and osteochondral destruction, as correlated with various demographic factors. Eighty surgically treated patients with intra-articular tumors (knee: 49, ankle and foot: 12, hip: 10, others: 9) were included in this study. Factors including age, disease type (diffuse/localized), location, existence of osteochondral destruction were correlated with local recurrence or development/progression of osteochondral destruction. The 5-year local recurrence free survival rate was 71.4%. Diffuse type (n = 59, localized: n = 21) (P = 0.023) and knee location (P = 0.002) were independent risk factors for local recurrence. Diffuse type (P = 0.009) was a significant risk factor, and knee location (P = 0.001) was a negative factor for osteochondral destruction at the initial examination. Progression of osteochondral destruction was observed more often in cases with local recurrence (P = 0.040) and findings of osteochondral destruction at the initial examination (P = 0.029). Diffuse type is a factor that should be noted for both local recurrence and osteochondral destruction, while local recurrence occurs but osteochondral destruction is less observed in the knee.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] The surgical outcome and recurrence rate of tenosynovial giant cell tumor in the elbow: a literature review
    Al Farii, Humaid
    Zhou, Sarah
    Turcotte, Robert
    JOURNAL OF SHOULDER AND ELBOW SURGERY, 2019, 28 (09) : 1835 - 1840
  • [2] Malignant diffuse-type tenosynovial giant cell tumor of the buttock
    Kondo, Reiichiro
    Akiba, Jun
    Hiraoka, Koji
    Hisaoka, Masanori
    Hashimoto, Hiroshi
    Kage, Masayoshi
    Yano, Hirohisa
    PATHOLOGY INTERNATIONAL, 2012, 62 (08) : 559 - 564
  • [3] Diffuse-Type Tenosynovial Giant Cell Tumor An Update of Current Management Strategies
    Naja, Ahmad
    Abboud, Abdallah
    Masrouha, Karim
    Ghert, Michelle
    Saghieh, Said
    BULLETIN OF THE HOSPITAL FOR JOINT DISEASES, 2024, 82 (03): : 178 - 185
  • [4] Diffuse-type tenosynovial giant cell tumor of the temporomandibular joint with skull base invasion: a report of cases with literature review
    Liu, Ying
    Fan, Bao-hua
    Tan, Yi-ran
    Zhu, Dong-wang
    Dong, Min-jun
    Wang, Li-zhen
    Li, Jiang
    Sun, Jian
    Zhang, Chen-ping
    Ji, Tong
    Yang, Wen-jun
    Abdelrehem, Ahmed
    Wu, Yi-qun
    Zhong, Lai-ping
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2021, 131 (01): : 16 - 26
  • [5] Tenosynovial Giant Cell Tumor: Incidence, Prevalence, Patient Characteristics, and Recurrence. A Registry-based Cohort Study in Denmark
    Ehrenstein, Vera
    Andersen, Soren L.
    Qazi, Ibrahim
    Sankar, Neil
    Pedersen, Alma B.
    Sikorski, Robert
    Acquavella, John F.
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (10) : 1476 - 1483
  • [6] Diffuse Type Tenosynovial Giant Cell Tumor of the Ankle
    Zhao, Jing-Jing
    Xie, Ming
    Huang, Ruo-Kun
    Xiao, Kai
    CHINESE MEDICAL JOURNAL, 2016, 129 (07) : 881 - 882
  • [7] Malignant Diffuse-Type Tenosynovial Giant Cell Tumor in the Subcutaneous Tissue of the Midthigh: A Report of a Rare Tumor in an Unusual Location
    Salem, Omar
    Kurdi, Khalid
    Joudeh, Amani
    Al-Dhafiri, Ahmad
    Alkhunaizi, Zahra
    Al Absi, Emad
    CASE REPORTS IN ORTHOPEDICS, 2022, 2022
  • [8] Incomplete resection increases the risk of local recurrence and negatively affects functional outcome in patients with tenosynovial giant cell tumor of the hindfoot
    Tsukamoto, Shinji
    Zucchini, Riccardo
    Staals, Eric L.
    Mavrogenis, Andreas F.
    Akahane, Manabu
    Palmerini, Emanuela
    Errani, Costantino
    Tanaka, Yasuhito
    FOOT AND ANKLE SURGERY, 2020, 26 (07) : 822 - 827
  • [9] Tenosynovial giant cell tumor of the suboccipital region - A rare, benign neoplasm in this location
    Singh, Rahul
    Stienen, Martin N.
    Ganjoo, Kristen
    Kolahi, Kevin S.
    Cayrol, Romain
    Charville, Gregory W.
    Born, Donald E.
    Zygourakis, Corinna C.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2020, 78 : 413 - 415
  • [10] TENOSYNOVIAL GIANT-CELL TUMOR IN THE KNEE-JOINT
    KIM, SJ
    CHOI, NH
    LEE, SC
    ARTHROSCOPY, 1995, 11 (02): : 213 - 215